insulin resistance and chronic hepatitis c

Clicks: 353
ID: 143445
2016
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #6 of 34 articles by views in indian journal of chemical technology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Aim. To estimate the spread of insulin resistance (IR) in patients with chronic hepatitis C (CHC) and to define the role of IR in the development of hepatic steatosis (HS) and in the progression of liver fibrosis (LF), as well as the impact of IR on the results of antiviral therapy (AVT). Subjects and methods. A total of 211 patients with CHC were examined. A comparison group consisted of 75 patients with chronic hepatitis B (CHB). The patients were divided according to the presence and absence of IR and type 2 diabetes mellitus (DM). IR was analyzed in patients with CHC with a body mass index (BMI) of
Reference Key
tkachenko2016insulin Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;L I Tkachenko;V V Maleev
Journal indian journal of chemical technology
Year 2016
DOI
10.17116/terarkh2016881129-36
URL
https://ter-arkhiv.ru/0040-3660/article/viewFile/32060/pdf
Keywords
Chronic Hepatitis C Liver Fibrosis insulin resistance antiviral therapy steatosis

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.